Discovery of a novel series of potent S1P1 agonists
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (5) , 1516-1519
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disordersExpert Opinion on Therapeutic Patents, 2008
- Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720Blood, 2006
- S1P1-Selective In Vivo-Active Agonists from High- Throughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and FateChemistry & Biology, 2005
- Polymer-Supported Mukaiyama Reagent: A Useful Coupling Reagent for the Synthesis of Esters and AmidesOrganic Letters, 2004
- FTY720: Sphingosine 1-Phosphate Receptor-1 in the Control of Lymphocyte Egress and Endothelial Barrier FunctionAmerican Journal of Transplantation, 2004
- Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor SubtypesThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor AgonistsScience, 2002